Australia Breast Cancer Brachytherapy Market Size & Outlook

The breast cancer brachytherapy market in Australia is expected to reach a projected revenue of US$ 3.2 million by 2027. A compound annual growth rate of 8.1% is expected of Australia breast cancer brachytherapy market from 2019 to 2027.
Revenue, 2018 (US$M)
$1.6
Forecast, 2027 (US$M)
$3.2
CAGR, 2019 - 2027
8.1%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia breast cancer brachytherapy market, 2015-2027 (US$M)

Australia breast cancer brachytherapy market, 2015-2027 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia breast cancer brachytherapy market highlights

  • The Australia breast cancer brachytherapy market generated a revenue of USD 1.6 million in 2018 and is expected to reach USD 3.2 million by 2027.
  • The Australia market is expected to grow at a CAGR of 8.1% from 2019 to 2027.
  • In terms of segment, high dose rate (hdr) was the largest revenue generating technology in 2018.
  • High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.

Breast cancer brachytherapy market data book summary

Market revenue in 2018USD 1.6 million
Market revenue in 2027USD 3.2 million
Growth rate8.1% (CAGR from 2018 to 2027)
Largest segmentHigh dose rate (hdr)
Fastest growing segmentHigh Dose Rate (HDR)
Historical data2015 - 2017
Base year2018
Forecast period2019 - 2027
Quantitative unitsRevenue in USD million
Market segmentationHigh Dose Rate (HDR), Low Dose Rate (LDR)
Key market players worldwideEckert & Ziegler Bebig SA, Elekta AB ADR, Siemens Healthineers AG ADR, Icad Inc, Hologic Inc, Merit Medical Systems Inc

Other key industry trends

  • In terms of revenue, Australia accounted for 2.7% of the global breast cancer brachytherapy market in 2018.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Asia Pacific, Japan breast cancer brachytherapy market is projected to lead the regional market in terms of revenue in 2027.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1.5 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Breast Cancer Brachytherapy Market Companies

Name Profile # Employees HQ Website
Eckert & Ziegler Bebig SA View profile 501-1000 Seneffe, Hainaut, Belgium, Europe http://www.ezag.com/home/
Merit Medical Systems Inc View profile 6950 1600 West Merit Parkway, South Jordan, UT, United States, 84095 https://www.merit.com
Icad Inc View profile 69 98 Spit Brook Road, Suite 100, Nashua, NH, United States, 03062 https://www.icadmed.com
Elekta AB ADR View profile 4584 Kungstensgatan 18, Box 7593, Stockholm, Sweden, SE-103 93 https://www.elekta.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com

Australia breast cancer brachytherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.


High dose rate (hdr) was the largest segment with a revenue share of 62.5% in 2018. Horizon Databook has segmented the Australia breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.


  • Australia Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
    • High Dose Rate (HDR)
    • Low Dose Rate (LDR)

Reasons to subscribe to Australia breast cancer brachytherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia breast cancer brachytherapy market databook

  • Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia breast cancer brachytherapy market, including forecasts for subscribers. This country databook contains high-level insights into Australia breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia breast cancer brachytherapy market size, by technology, 2015-2027 (US$M)

Australia Breast Cancer Brachytherapy Market Share, 2018 & 2027 (US$M)

Australia breast cancer brachytherapy market size, by technology, 2015-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online